Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 61 entries
Sorted by: Best Match Show Resources per page
Illustrative and historic cases of phenoconversion.

American journal of translational research

Michaud V, Dow P, Turgeon J.
PMID: 35035679
Am J Transl Res. 2021 Dec 15;13(12):13328-13335. eCollection 2021.

Intersubject variability in drug response, whether related to efficacy or toxicity, is well recognized clinically. Over the years, drug selection from our pharmacologic armamentarium has moved from providers' preferred choices to more personalized treatments as clinicians' decisions are guided...

Cite
Michaud V, Dow P, Turgeon J. Illustrative and historic cases of phenoconversion. Am J Transl Res. 2021;13(12):13328-13335
Michaud, V., Dow, P., & Turgeon, J. (2021). Illustrative and historic cases of phenoconversion. American journal of translational research, 13(12), 13328-13335.
Michaud, Veronique, et al. "Illustrative and historic cases of phenoconversion." American journal of translational research vol. 13,12 (2021): 13328-13335.
Michaud V, Dow P, Turgeon J. Illustrative and historic cases of phenoconversion. Am J Transl Res. 2021 Dec 15;13(12):13328-13335. eCollection 2021. PMID: 35035679; PMCID: PMC8748136.
Copy Download .nbib Format: NLM
Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report.

European heart journal. Case reports

Karelas D, Papanikolaou J, Kossyvakis C, Platogiannis D.
PMID: 34909576
Eur Heart J Case Rep. 2021 Nov 30;5(12):ytab485. doi: 10.1093/ehjcr/ytab485. eCollection 2021 Dec.

BACKGROUND: Atrial fibrillation in WolffCASE SUMMARY: We report a case of a 43-year-old man with unremarkable cardiac history who presented due to sudden-onset feeling of palpitations and pre-syncope after strenuous lifting. Electrocardiography depicted fast pre-excited AF. The shortest pre-excited...

Cite
Karelas D, Papanikolaou J, Kossyvakis C, et al. Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report. Eur Heart J Case Rep. 2021;5(12):ytab485doi: 10.1093/ehjcr/ytab485.
Karelas, D., Papanikolaou, J., Kossyvakis, C., & Platogiannis, D. (2021). Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report. European heart journal. Case reports, 5(12), ytab485. https://doi.org/10.1093/ehjcr/ytab485
Karelas, Dimitrios, et al. "Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report." European heart journal. Case reports vol. 5,12 (2021): ytab485. doi: https://doi.org/10.1093/ehjcr/ytab485
Karelas D, Papanikolaou J, Kossyvakis C, Platogiannis D. Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report. Eur Heart J Case Rep. 2021 Nov 30;5(12):ytab485. doi: 10.1093/ehjcr/ytab485. eCollection 2021 Dec. PMID: 34909576; PMCID: PMC8665683.
Copy Download .nbib Format: NLM
Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim.

Acta Cardiologica Sinica

Trebach J, Mohan S, Hoffman RS.
PMID: 33976520
Acta Cardiol Sin. 2021 May;37(3):324. doi: 10.6515/ACS.202105_37(3).20210313B.

No abstract available.

Cite
Trebach J, Mohan S, Hoffman RS. Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim. Acta Cardiol Sin. 2021;37(3):324doi: 10.6515/ACS.202105_37(3).20210313B.
Trebach, J., Mohan, S., & Hoffman, R. S. (2021). Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim. Acta Cardiologica Sinica, 37(3), 324. https://doi.org/10.6515/ACS.202105_37(3).20210313B
Trebach, Joshua, et al. "Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim." Acta Cardiologica Sinica vol. 37,3 (2021): 324. doi: https://doi.org/10.6515/ACS.202105_37(3).20210313B
Trebach J, Mohan S, Hoffman RS. Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim. Acta Cardiol Sin. 2021 May;37(3):324. doi: 10.6515/ACS.202105_37(3).20210313B. PMID: 33976520; PMCID: PMC8107704.
Copy Download .nbib Format: NLM
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Chiou WR, Huang CC, Lin PL, Chuang JY, Liu LY, Su MI, Liao FC, Chen CY, Kuo JY, Tsai CT, Wu YJ, Lee YH.
PMID: 33369716
Am J Cardiovasc Drugs. 2021 Jul;21(4):459-469. doi: 10.1007/s40256-020-00454-6. Epub 2020 Dec 28.

INTRODUCTION: Rivaroxaban reduces the risk of thromboembolism in atrial fibrillation (AF) patients, who often also receive antiarrhythmic drugs (AADs) to maintain sinus rhythm. Current guidelines contraindicate concomitant use of rivaroxaban with the popular AAD dronedarone, despite little data demonstrating...

Cite
Chiou WR, Huang CC, Lin PL, et al. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation. Am J Cardiovasc Drugs. 2020;21(4):459-469doi: 10.1007/s40256-020-00454-6.
Chiou, W. R., Huang, C. C., Lin, P. L., Chuang, J. Y., Liu, L. Y., Su, M. I., Liao, F. C., Chen, C. Y., Kuo, J. Y., Tsai, C. T., Wu, Y. J., & Lee, Y. H. (2021). Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation. American journal of cardiovascular drugs : drugs, devices, and other interventions, 21(4), 459-469. https://doi.org/10.1007/s40256-020-00454-6
Chiou, Wei-Ru, et al. "Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation." American journal of cardiovascular drugs : drugs, devices, and other interventions vol. 21,4 (2021): 459-469. doi: https://doi.org/10.1007/s40256-020-00454-6
Chiou WR, Huang CC, Lin PL, Chuang JY, Liu LY, Su MI, Liao FC, Chen CY, Kuo JY, Tsai CT, Wu YJ, Lee YH. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation. Am J Cardiovasc Drugs. 2021 Jul;21(4):459-469. doi: 10.1007/s40256-020-00454-6. Epub 2020 Dec 28. PMID: 33369716.
Copy Download .nbib Format: NLM
The Efficacy Comparison Between Guan-Fu Base A Hydrochloric Injection vs. Propafenone Hydrochloric Injection in the Treatment of Arrhythmia: Systemic Review and Meta-Analysis.

Frontiers in cardiovascular medicine

Song J, Tang Y, Gao C, Hou X, Liu X, Xu Z.
PMID: 34805300
Front Cardiovasc Med. 2021 Nov 05;8:723932. doi: 10.3389/fcvm.2021.723932. eCollection 2021.

No abstract available.

Cite
Song J, Tang Y, Gao C, et al. The Efficacy Comparison Between Guan-Fu Base A Hydrochloric Injection vs. Propafenone Hydrochloric Injection in the Treatment of Arrhythmia: Systemic Review and Meta-Analysis. Front Cardiovasc Med. 2021;8:723932doi: 10.3389/fcvm.2021.723932.
Song, J., Tang, Y., Gao, C., Hou, X., Liu, X., & Xu, Z. (2021). The Efficacy Comparison Between Guan-Fu Base A Hydrochloric Injection vs. Propafenone Hydrochloric Injection in the Treatment of Arrhythmia: Systemic Review and Meta-Analysis. Frontiers in cardiovascular medicine, 8723932. https://doi.org/10.3389/fcvm.2021.723932
Song, Jinming, et al. "The Efficacy Comparison Between Guan-Fu Base A Hydrochloric Injection vs. Propafenone Hydrochloric Injection in the Treatment of Arrhythmia: Systemic Review and Meta-Analysis." Frontiers in cardiovascular medicine vol. 8 (2021): 723932. doi: https://doi.org/10.3389/fcvm.2021.723932
Song J, Tang Y, Gao C, Hou X, Liu X, Xu Z. The Efficacy Comparison Between Guan-Fu Base A Hydrochloric Injection vs. Propafenone Hydrochloric Injection in the Treatment of Arrhythmia: Systemic Review and Meta-Analysis. Front Cardiovasc Med. 2021 Nov 05;8:723932. doi: 10.3389/fcvm.2021.723932. eCollection 2021. PMID: 34805300; PMCID: PMC8602695.
Copy Download .nbib Format: NLM
Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?.

Journal of cardiovascular pharmacology and therapeutics

Gallik D, Altamirano J, Singh BN.
PMID: 10684451
J Cardiovasc Pharmacol Ther. 1997 Apr;2(2):135-144. doi: 10.1177/107424849700200207.

Atrial fibrillation and atrial flutter, the most frequently encountered tachyarrhythmias requiring treatment, have become a major focus for clinical and basic research in recent years. Restoration and maintenance of sinus rhythmn, having been shown to improve exercise capacity, alleviate...

Cite
Gallik D, Altamirano J, Singh BN. Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?. J Cardiovasc Pharmacol Ther. 1997;2(2):135-144doi: 10.1177/107424849700200207.
Gallik, D., Altamirano, J., & Singh, B. N. (1997). Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?. Journal of cardiovascular pharmacology and therapeutics, 2(2), 135-144. https://doi.org/10.1177/107424849700200207
Gallik, et al. "Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?." Journal of cardiovascular pharmacology and therapeutics vol. 2,2 (1997): 135-144. doi: https://doi.org/10.1177/107424849700200207
Gallik D, Altamirano J, Singh BN. Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?. J Cardiovasc Pharmacol Ther. 1997 Apr;2(2):135-144. doi: 10.1177/107424849700200207. PMID: 10684451.
Copy Download .nbib Format: NLM
Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study.

Journal of cardiovascular pharmacology and therapeutics

Fak AS, Tezcan H, Caymaz O, Tokay S, Oktay S, Oktay A.
PMID: 10684466
J Cardiovasc Pharmacol Ther. 1997 Oct;2(4):251-258. doi: 10.1177/107424849700200403.

BACKGROUND: Propafenone has been claimed to be effective in converting atrial fibrillation and flutter to sinus rhythm; however, controlled clinical trials have reported variable results, and data about the safety of propafenone in the setting of heart failure are...

Cite
Fak AS, Tezcan H, Caymaz O, et al. Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study. J Cardiovasc Pharmacol Ther. 1997;2(4):251-258doi: 10.1177/107424849700200403.
Fak, A. S., Tezcan, H., Caymaz, O., Tokay, S., Oktay, S., & Oktay, A. (1997). Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study. Journal of cardiovascular pharmacology and therapeutics, 2(4), 251-258. https://doi.org/10.1177/107424849700200403
Fak, et al. "Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study." Journal of cardiovascular pharmacology and therapeutics vol. 2,4 (1997): 251-258. doi: https://doi.org/10.1177/107424849700200403
Fak AS, Tezcan H, Caymaz O, Tokay S, Oktay S, Oktay A. Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study. J Cardiovasc Pharmacol Ther. 1997 Oct;2(4):251-258. doi: 10.1177/107424849700200403. PMID: 10684466.
Copy Download .nbib Format: NLM
Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Abd El Rasoul S, Shazly GA.
PMID: 29158720
Saudi Pharm J. 2017 Nov;25(7):1086-1092. doi: 10.1016/j.jsps.2017.05.003. Epub 2017 May 20.

Propafenone HCl (PPH), an antiarrhythmic drug, has a bitter taste, short half-life, delayed drug dissolution and side effects. Thus, the purpose of this work is to develop orally fast dissolving tablets (OFDTs) containing PPH to provide a rapid drug...

Cite
Abd El Rasoul S, Shazly GA. Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method. Saudi Pharm J. 2017;25(7):1086-1092doi: 10.1016/j.jsps.2017.05.003.
Abd El Rasoul, S., & Shazly, G. A. (2017). Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 25(7), 1086-1092. https://doi.org/10.1016/j.jsps.2017.05.003
Abd El Rasoul, Saleh, and Shazly, Gamal A. "Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 25,7 (2017): 1086-1092. doi: https://doi.org/10.1016/j.jsps.2017.05.003
Abd El Rasoul S, Shazly GA. Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method. Saudi Pharm J. 2017 Nov;25(7):1086-1092. doi: 10.1016/j.jsps.2017.05.003. Epub 2017 May 20. PMID: 29158720; PMCID: PMC5681323.
Copy Download .nbib Format: NLM
Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept.

Pharmacology research & perspectives

Spork M, Sohail MI, Schmid D, Ecker GF, Freissmuth M, Chiba P, Stockner T.
PMID: 28603639
Pharmacol Res Perspect. 2017 May 26;5(3):e00325. doi: 10.1002/prp2.325. eCollection 2017 Jun.

Point mutations of ATP-binding cassette (ABC) proteins are a common cause of human diseases. Available crystal structures indicate a similarity in the architecture of several members of this protein family. Their molecular architecture makes these proteins vulnerable to mutation,...

Cite
Spork M, Sohail MI, Schmid D, et al. Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept. Pharmacol Res Perspect. 2017;5(3):e00325doi: 10.1002/prp2.325.
Spork, M., Sohail, M. I., Schmid, D., Ecker, G. F., Freissmuth, M., Chiba, P., & Stockner, T. (2017). Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept. Pharmacology research & perspectives, 5(3), e00325. https://doi.org/10.1002/prp2.325
Spork, Matthias, et al. "Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept." Pharmacology research & perspectives vol. 5,3 (2017): e00325. doi: https://doi.org/10.1002/prp2.325
Spork M, Sohail MI, Schmid D, Ecker GF, Freissmuth M, Chiba P, Stockner T. Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept. Pharmacol Res Perspect. 2017 May 26;5(3):e00325. doi: 10.1002/prp2.325. eCollection 2017 Jun. PMID: 28603639; PMCID: PMC5464349.
Copy Download .nbib Format: NLM
Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment.

American journal of therapeutics

Torres D, Parrinello G, Paterna S, Bellanca M, Licata G.
PMID: 21248622
Am J Ther. 2011 Jan 18; doi: 10.1097/MJT.0b013e3181fc2fab. Epub 2011 Jan 18.

Propafenone is a membrane-stabilizing agent belonging to a subgroup of the Vaughan Williams class I antidysrhythmic agents, structurally resembling propranolol and characterized by weaker beta-blocking activity. Despite respiratory complications having been reported as examples of side effects, very few...

Cite
Torres D, Parrinello G, Paterna S, et al. Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. Am J Ther. 2011;doi: 10.1097/MJT.0b013e3181fc2fab.
Torres, D., Parrinello, G., Paterna, S., Bellanca, M., & Licata, G. (2011). Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. American journal of therapeutics, . https://doi.org/10.1097/MJT.0b013e3181fc2fab
Torres, Daniele, et al. "Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment." American journal of therapeutics vol. (2011). doi: https://doi.org/10.1097/MJT.0b013e3181fc2fab
Torres D, Parrinello G, Paterna S, Bellanca M, Licata G. Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. Am J Ther. 2011 Jan 18; doi: 10.1097/MJT.0b013e3181fc2fab. Epub 2011 Jan 18. PMID: 21248622.
Copy Download .nbib Format: NLM
Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone.

Patient related outcome measures

Chahal CA, Ali O, Hunter RJ, Schilling RJ.
PMID: 23378791
Patient Relat Outcome Meas. 2012;3:95-103. doi: 10.2147/PROM.S16678. Epub 2012 Dec 19.

Atrial fibrillation (AF) is a substantial cause of mortality and morbidity in the Western world. It is a massive burden on health care systems, and its prevalence is expected to double over the next 20 years. Trials evaluating antiarrhythmic...

Cite
Chahal CA, Ali O, Hunter RJ, et al. Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone. Patient Relat Outcome Meas. 2012;3:95-103doi: 10.2147/PROM.S16678.
Chahal, C. A., Ali, O., Hunter, R. J., & Schilling, R. J. (2012). Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone. Patient related outcome measures, 395-103. https://doi.org/10.2147/PROM.S16678
Chahal, C Anwar A, et al. "Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone." Patient related outcome measures vol. 3 (2012): 95-103. doi: https://doi.org/10.2147/PROM.S16678
Chahal CA, Ali O, Hunter RJ, Schilling RJ. Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone. Patient Relat Outcome Meas. 2012;3:95-103. doi: 10.2147/PROM.S16678. Epub 2012 Dec 19. PMID: 23378791; PMCID: PMC3557702.
Copy Download .nbib Format: NLM
Unusual amiodarone toxicity in a child.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Kakavand B, Di Sessa TG.
PMID: 23055871
J Pediatr Pharmacol Ther. 2008 Apr;13(2):93-5. doi: 10.5863/1551-6776-13.2.93.

No abstract available.

Cite
Kakavand B, Di Sessa TG. Unusual amiodarone toxicity in a child. J Pediatr Pharmacol Ther. 2008;13(2):93-5doi: 10.5863/1551-6776-13.2.93.
Kakavand, B., & Di Sessa, T. G. (2008). Unusual amiodarone toxicity in a child. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 13(2), 93-5. https://doi.org/10.5863/1551-6776-13.2.93
Kakavand, Bahram, and Di Sessa, Thomas G. "Unusual amiodarone toxicity in a child." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 13,2 (2008): 93-5. doi: https://doi.org/10.5863/1551-6776-13.2.93
Kakavand B, Di Sessa TG. Unusual amiodarone toxicity in a child. J Pediatr Pharmacol Ther. 2008 Apr;13(2):93-5. doi: 10.5863/1551-6776-13.2.93. PMID: 23055871; PMCID: PMC3462064.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 61 entries